EMEA (Europe, Middle East and Africa) Gastrointestinal Therapeutics Market Report 2017

August 2017 | 129 pages | ID: EA87D6D113AEN
QYResearch

Abstracts

In this report, the EMEA Gastrointestinal Therapeutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Gastrointestinal Therapeutics for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Gastrointestinal Therapeutics market competition by top manufacturers/players, with Gastrointestinal Therapeutics sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Johnson & Johnson
• AbbVie
• Allergan
• Takeda
• Novartis
• Pfizer
• GlaxoSmithKline
• Merck
• UCB (Belgium)
• F. Hoffmann-La Roche
• Eli Lilly
• AstraZeneca
• Procter & Gamble
• Eisai
• Shire Pharmaceuticals
• Ferring Pharmaceuticals
• Kyowa Hakko Kirin
• Salix Pharmaceuticals
• Ono Pharmaceutical
• TSD Japan
• RedHill Biopharma
• Kaken Pharmaceutical
• Amgen
• Synergy Pharmaceuticals
• Ajinomoto
• Kissei Pharmaceutical
• Hutchison Medi Pharma

On the basis of product, this report displays the sales volume (K Pcs), revenue (Million USD), product price (USD/Pcs), market share and growth rate of each type, primarily split into

• Tablets
• Injection

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Pcs), market share and growth rate of Gastrointestinal Therapeutics for each application, including

• IBD
• Irritable Bowel Syndrome (IBS)
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Gastrointestinal Therapeutics Market Report 2017

1 GASTROINTESTINAL THERAPEUTICS OVERVIEW

1.1 Product Overview and Scope of Gastrointestinal Therapeutics
1.2 Classification of Gastrointestinal Therapeutics
  1.2.1 EMEA Gastrointestinal Therapeutics Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Gastrointestinal Therapeutics Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Tablets
  1.2.4 Injection
1.3 EMEA Gastrointestinal Therapeutics Market by Application/End Users
  1.3.1 EMEA Gastrointestinal Therapeutics Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 IBD
  1.3.3 Irritable Bowel Syndrome (IBS)
  1.3.4 Other
1.4 EMEA Gastrointestinal Therapeutics Market by Region
  1.4.1 EMEA Gastrointestinal Therapeutics Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Gastrointestinal Therapeutics (2012-2022)
  1.5.1 EMEA Gastrointestinal Therapeutics Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Gastrointestinal Therapeutics Revenue and Growth Rate (2012-2022)

2 EMEA GASTROINTESTINAL THERAPEUTICS COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Gastrointestinal Therapeutics Market Competition by Players/Manufacturers
  2.1.1 EMEA Gastrointestinal Therapeutics Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Gastrointestinal Therapeutics Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Gastrointestinal Therapeutics Sale Price by Players (2012-2017)
2.2 EMEA Gastrointestinal Therapeutics (Volume and Value) by Type/Product Category
  2.2.1 EMEA Gastrointestinal Therapeutics Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Gastrointestinal Therapeutics Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Gastrointestinal Therapeutics Sale Price by Type (2012-2017)
2.3 EMEA Gastrointestinal Therapeutics (Volume) by Application
2.4 EMEA Gastrointestinal Therapeutics (Volume and Value) by Region
  2.4.1 EMEA Gastrointestinal Therapeutics Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Gastrointestinal Therapeutics Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Gastrointestinal Therapeutics Sales Price by Region (2012-2017)

3 EUROPE GASTROINTESTINAL THERAPEUTICS (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Gastrointestinal Therapeutics Sales and Value (2012-2017)
  3.1.1 Europe Gastrointestinal Therapeutics Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Gastrointestinal Therapeutics Revenue and Growth Rate (2012-2017)
3.2 Europe Gastrointestinal Therapeutics Sales and Market Share by Type
3.3 Europe Gastrointestinal Therapeutics Sales and Market Share by Application
3.4 Europe Gastrointestinal Therapeutics Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Gastrointestinal Therapeutics Sales Volume by Countries (2012-2017)
  3.4.2 Europe Gastrointestinal Therapeutics Revenue by Countries (2012-2017)
  3.4.3 Germany Gastrointestinal Therapeutics Sales and Growth Rate (2012-2017)
  3.4.4 France Gastrointestinal Therapeutics Sales and Growth Rate (2012-2017)
  3.4.5 UK Gastrointestinal Therapeutics Sales and Growth Rate (2012-2017)
  3.4.6 Russia Gastrointestinal Therapeutics Sales and Growth Rate (2012-2017)
  3.4.7 Italy Gastrointestinal Therapeutics Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Gastrointestinal Therapeutics Sales and Growth Rate (2012-2017)

4 MIDDLE EAST GASTROINTESTINAL THERAPEUTICS (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Gastrointestinal Therapeutics Sales and Value (2012-2017)
  4.1.1 Middle East Gastrointestinal Therapeutics Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Gastrointestinal Therapeutics Revenue and Growth Rate (2012-2017)
4.2 Middle East Gastrointestinal Therapeutics Sales and Market Share by Type
4.3 Middle East Gastrointestinal Therapeutics Sales and Market Share by Application
4.4 Middle East Gastrointestinal Therapeutics Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Gastrointestinal Therapeutics Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Gastrointestinal Therapeutics Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Gastrointestinal Therapeutics Sales and Growth Rate (2012-2017)
  4.4.4 Israel Gastrointestinal Therapeutics Sales and Growth Rate (2012-2017)
  4.4.5 UAE Gastrointestinal Therapeutics Sales and Growth Rate (2012-2017)
  4.4.6 Iran Gastrointestinal Therapeutics Sales and Growth Rate (2012-2017)

5 AFRICA GASTROINTESTINAL THERAPEUTICS (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Gastrointestinal Therapeutics Sales and Value (2012-2017)
  5.1.1 Africa Gastrointestinal Therapeutics Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Gastrointestinal Therapeutics Revenue and Growth Rate (2012-2017)
5.2 Africa Gastrointestinal Therapeutics Sales and Market Share by Type
5.3 Africa Gastrointestinal Therapeutics Sales and Market Share by Application
5.4 Africa Gastrointestinal Therapeutics Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Gastrointestinal Therapeutics Sales Volume by Countries (2012-2017)
  5.4.2 Africa Gastrointestinal Therapeutics Revenue by Countries (2012-2017)
  5.4.3 South Africa Gastrointestinal Therapeutics Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Gastrointestinal Therapeutics Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Gastrointestinal Therapeutics Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Gastrointestinal Therapeutics Sales and Growth Rate (2012-2017)

6 EMEA GASTROINTESTINAL THERAPEUTICS MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Johnson & Johnson
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Gastrointestinal Therapeutics Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Johnson & Johnson Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 AbbVie
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Gastrointestinal Therapeutics Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 AbbVie Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Allergan
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Gastrointestinal Therapeutics Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Allergan Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Takeda
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Gastrointestinal Therapeutics Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Takeda Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Novartis
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Gastrointestinal Therapeutics Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Novartis Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Pfizer
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Gastrointestinal Therapeutics Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Pfizer Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 GlaxoSmithKline
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Gastrointestinal Therapeutics Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 GlaxoSmithKline Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Merck
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Gastrointestinal Therapeutics Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Merck Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 UCB (Belgium)
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Gastrointestinal Therapeutics Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 UCB (Belgium) Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 F. Hoffmann-La Roche
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Gastrointestinal Therapeutics Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 F. Hoffmann-La Roche Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Eli Lilly
6.12 AstraZeneca
6.13 Procter & Gamble
6.14 Eisai
6.15 Shire Pharmaceuticals
6.16 Ferring Pharmaceuticals
6.17 Kyowa Hakko Kirin
6.18 Salix Pharmaceuticals
6.19 Ono Pharmaceutical
6.20 TSD Japan
6.21 RedHill Biopharma
6.22 Kaken Pharmaceutical
6.23 Amgen
6.24 Synergy Pharmaceuticals
6.25 Ajinomoto
6.26 Kissei Pharmaceutical
6.27 Hutchison Medi Pharma

7 GASTROINTESTINAL THERAPEUTICS MANUFACTURING COST ANALYSIS

7.1 Gastrointestinal Therapeutics Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Gastrointestinal Therapeutics

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Gastrointestinal Therapeutics Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Gastrointestinal Therapeutics Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA GASTROINTESTINAL THERAPEUTICS MARKET FORECAST (2017-2022)

11.1 EMEA Gastrointestinal Therapeutics Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Gastrointestinal Therapeutics Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Gastrointestinal Therapeutics Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Gastrointestinal Therapeutics Price and Trend Forecast (2017-2022)
11.2 EMEA Gastrointestinal Therapeutics Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Gastrointestinal Therapeutics Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Gastrointestinal Therapeutics Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Gastrointestinal Therapeutics Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Gastrointestinal Therapeutics Sales Forecast by Type (2017-2022)
11.7 EMEA Gastrointestinal Therapeutics Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Gastrointestinal Therapeutics
Figure EMEA Gastrointestinal Therapeutics Sales Volume (K Pcs) by Type (2012-2022)
Figure EMEA Gastrointestinal Therapeutics Sales Volume Market Share by Type (Product Category) in 2016
Figure Tablets Product Picture
Figure Injection Product Picture
Figure EMEA Gastrointestinal Therapeutics Sales Volume (K Pcs) by Application (2012-2022)
Figure EMEA Sales Market Share of Gastrointestinal Therapeutics by Application in 2016
Figure IBD Examples
Table Key Downstream Customer in IBD
Figure Irritable Bowel Syndrome (IBS) Examples
Table Key Downstream Customer in Irritable Bowel Syndrome (IBS)
Figure Other Examples
Table Key Downstream Customer in Other
Figure EMEA Gastrointestinal Therapeutics Market Size (Million USD) by Region (2012-2022)
Figure Europe Gastrointestinal Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Gastrointestinal Therapeutics Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Gastrointestinal Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Gastrointestinal Therapeutics Revenue (Million USD) Status and Forecast by Countries
Figure Africa Gastrointestinal Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Gastrointestinal Therapeutics Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Gastrointestinal Therapeutics Sales Volume and Growth Rate (2012-2022)
Figure EMEA Gastrointestinal Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Gastrointestinal Therapeutics Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table EMEA Gastrointestinal Therapeutics Sales Volume (K Pcs) of Major Players (2012-2017)
Table EMEA Gastrointestinal Therapeutics Sales Share by Players (2012-2017)
Figure 2016 Gastrointestinal Therapeutics Sales Share by Players
Figure 2017 Gastrointestinal Therapeutics Sales Share by Players
Figure EMEA Gastrointestinal Therapeutics Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Gastrointestinal Therapeutics Revenue (Million USD) by Players (2012-2017)
Table EMEA Gastrointestinal Therapeutics Revenue Share by Players (2012-2017)
Table 2016 EMEA Gastrointestinal Therapeutics Revenue Share by Players
Table 2017 EMEA Gastrointestinal Therapeutics Revenue Share by Players
Table EMEA Gastrointestinal Therapeutics Sale Price (USD/Pcs) by Players (2012-2017)
Table EMEA Gastrointestinal Therapeutics Sales (K Pcs) and Market Share by Type (2012-2017)
Table EMEA Gastrointestinal Therapeutics Sales Share by Type (2012-2017)
Figure Sales Market Share of Gastrointestinal Therapeutics by Type (2012-2017)
Figure EMEA Gastrointestinal Therapeutics Sales Market Share by Type (2012-2017)
Table EMEA Gastrointestinal Therapeutics Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Gastrointestinal Therapeutics Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Gastrointestinal Therapeutics by Type in 2016
Table EMEA Gastrointestinal Therapeutics Sale Price (USD/Pcs) by Type (2012-2017)
Table EMEA Gastrointestinal Therapeutics Sales (K Pcs) and Market Share by Application (2012-2017)
Table EMEA Gastrointestinal Therapeutics Sales Share by Application (2012-2017)
Figure Sales Market Share of Gastrointestinal Therapeutics by Application (2012-2017)
Figure EMEA Gastrointestinal Therapeutics Sales Market Share by Application in 2016
Table EMEA Gastrointestinal Therapeutics Sales (K Pcs) and Market Share by Region (2012-2017)
Table EMEA Gastrointestinal Therapeutics Sales Share by Region (2012-2017)
Figure Sales Market Share of Gastrointestinal Therapeutics by Region (2012-2017)
Figure EMEA Gastrointestinal Therapeutics Sales Market Share in 2016
Table EMEA Gastrointestinal Therapeutics Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Gastrointestinal Therapeutics Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Gastrointestinal Therapeutics by Region (2012-2017)
Figure EMEA Gastrointestinal Therapeutics Revenue Market Share Regions in 2016
Table EMEA Gastrointestinal Therapeutics Sales Price (USD/Pcs) by Region (2012-2017)
Figure Europe Gastrointestinal Therapeutics Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Gastrointestinal Therapeutics Revenue and Growth Rate (2012-2017)
Table Europe Gastrointestinal Therapeutics Sales (K Pcs) by Type (2012-2017)
Table Europe Gastrointestinal Therapeutics Market Share by Type (2012-2017)
Figure Europe Gastrointestinal Therapeutics Market Share by Type in 2016
Table Europe Gastrointestinal Therapeutics Sales (K Pcs) by Application (2012-2017)
Table Europe Gastrointestinal Therapeutics Market Share by Application (2012-2017)
Figure Europe Gastrointestinal Therapeutics Market Share by Application in 2016
Table Europe Gastrointestinal Therapeutics Sales (K Pcs) by Countries (2012-2017)
Table Europe Gastrointestinal Therapeutics Sales Market Share by Countries (2012-2017)
Figure Europe Gastrointestinal Therapeutics Sales Market Share by Countries (2012-2017)
Figure Europe Gastrointestinal Therapeutics Sales Market Share by Countries in 2016
Table Europe Gastrointestinal Therapeutics Revenue (Million USD) by Countries (2012-2017)
Table Europe Gastrointestinal Therapeutics Revenue Market Share by Countries (2012-2017)
Figure Europe Gastrointestinal Therapeutics Revenue Market Share by Countries (2012-2017)
Figure Europe Gastrointestinal Therapeutics Revenue Market Share by Countries in 2016
Figure Germany Gastrointestinal Therapeutics Sales (K Pcs) and Growth Rate (2012-2017)
Figure France Gastrointestinal Therapeutics Sales (K Pcs) and Growth Rate (2012-2017)
Figure UK Gastrointestinal Therapeutics Sales (K Pcs) and Growth Rate (2012-2017)
Figure Russia Gastrointestinal Therapeutics Sales (K Pcs) and Growth Rate (2012-2017)
Figure Italy Gastrointestinal Therapeutics Sales (K Pcs) and Growth Rate (2012-2017)
Figure Benelux Gastrointestinal Therapeutics Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Gastrointestinal Therapeutics Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Gastrointestinal Therapeutics Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Gastrointestinal Therapeutics Sales (K Pcs) by Type (2012-2017)
Table Middle East Gastrointestinal Therapeutics Market Share by Type (2012-2017)
Figure Middle East Gastrointestinal Therapeutics Market Share by Type (2012-2017)
Table Middle East Gastrointestinal Therapeutics Sales (K Pcs) by Applications (2012-2017)
Table Middle East Gastrointestinal Therapeutics Market Share by Applications (2012-2017)
Figure Middle East Gastrointestinal Therapeutics Sales Market Share by Application in 2016
Table Middle East Gastrointestinal Therapeutics Sales Volume (K Pcs) by Countries (2012-2017)
Table Middle East Gastrointestinal Therapeutics Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Gastrointestinal Therapeutics Sales Volume Market Share by Countries in 2016
Table Middle East Gastrointestinal Therapeutics Revenue (Million USD) by Countries (2012-2017)
Table Middle East Gastrointestinal Therapeutics Revenue Market Share by Countries (2012-2017)
Figure Middle East Gastrointestinal Therapeutics Revenue Market Share by Countries (2012-2017)
Figure Middle East Gastrointestinal Therapeutics Revenue Market Share by Countries in 2016
Figure Saudi Arabia Gastrointestinal Therapeutics Sales (K Pcs) and Growth Rate (2012-2017)
Figure Israel Gastrointestinal Therapeutics Sales (K Pcs) and Growth Rate (2012-2017)
Figure UAE Gastrointestinal Therapeutics Sales (K Pcs) and Growth Rate (2012-2017)
Figure Iran Gastrointestinal Therapeutics Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Gastrointestinal Therapeutics Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Gastrointestinal Therapeutics Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Gastrointestinal Therapeutics Sales (K Pcs) by Type (2012-2017)
Table Africa Gastrointestinal Therapeutics Sales Market Share by Type (2012-2017)
Figure Africa Gastrointestinal Therapeutics Sales Market Share by Type (2012-2017)
Figure Africa Gastrointestinal Therapeutics Sales Market Share by Type in 2016
Table Africa Gastrointestinal Therapeutics Sales (K Pcs) by Application (2012-2017)
Table Africa Gastrointestinal Therapeutics Sales Market Share by Application (2012-2017)
Figure Africa Gastrointestinal Therapeutics Sales Market Share by Application (2012-2017)
Table Africa Gastrointestinal Therapeutics Sales Volume (K Pcs) by Countries (2012-2017)
Table Africa Gastrointestinal Therapeutics Sales Market Share by Countries (2012-2017)
Figure Africa Gastrointestinal Therapeutics Sales Market Share by Countries (2012-2017)
Figure Africa Gastrointestinal Therapeutics Sales Market Share by Countries in 2016
Table Africa Gastrointestinal Therapeutics Revenue (Million USD) by Countries (2012-2017)
Table Africa Gastrointestinal Therapeutics Revenue Market Share by Countries (2012-2017)
Figure Africa Gastrointestinal Therapeutics Revenue Market Share by Countries (2012-2017)
Figure Africa Gastrointestinal Therapeutics Revenue Market Share by Countries in 2016
Figure South Africa Gastrointestinal Therapeutics Sales (K Pcs) and Growth Rate (2012-2017)
Figure Nigeria Gastrointestinal Therapeutics Sales (K Pcs) and Growth Rate (2012-2017)
Figure Egypt Gastrointestinal Therapeutics Sales (K Pcs) and Growth Rate (2012-2017)
Figure Algeria Gastrointestinal Therapeutics Sales (K Pcs) and Growth Rate (2012-2017)
Table Johnson & Johnson Gastrointestinal Therapeutics Basic Information List
Table Johnson & Johnson Gastrointestinal Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Johnson & Johnson Gastrointestinal Therapeutics Sales (K Pcs) and Growth Rate (2012-2017)
Figure Johnson & Johnson Gastrointestinal Therapeutics Sales Market Share in EMEA (2012-2017)
Figure Johnson & Johnson Gastrointestinal Therapeutics Revenue Market Share in EMEA (2012-2017)
Table AbbVie Gastrointestinal Therapeutics Basic Information List
Table AbbVie Gastrointestinal Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure AbbVie Gastrointestinal Therapeutics Sales (K Pcs) and Growth Rate (2012-2017)
Figure AbbVie Gastrointestinal Therapeutics Sales Market Share in EMEA (2012-2017)
Figure AbbVie Gastrointestinal Therapeutics Revenue Market Share in EMEA (2012-2017)
Table Allergan Gastrointestinal Therapeutics Basic Information List
Table Allergan Gastrointestinal Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Allergan Gastrointestinal Therapeutics Sales (K Pcs) and Growth Rate (2012-2017)
Figure Allergan Gastrointestinal Therapeutics Sales Market Share in EMEA (2012-2017)
Figure Allergan Gastrointestinal Therapeutics Revenue Market Share in EMEA (2012-2017)
Table Takeda Gastrointestinal Therapeutics Basic Information List
Table Takeda Gastrointestinal Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Takeda Gastrointestinal Therapeutics Sales (K Pcs) and Growth Rate (2012-2017)
Figure Takeda Gastrointestinal Therapeutics Sales Market Share in EMEA (2012-2017)
Figure Takeda Gastrointestinal Therapeutics Revenue Market Share in EMEA (2012-2017)
Table Novartis Gastrointestinal Therapeutics Basic Information List
Table Novartis Gastrointestinal Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Novartis Gastrointestinal Therapeutics Sales (K Pcs) and Growth Rate (2012-2017)
Figure Novartis Gastrointestinal Therapeutics Sales Market Share in EMEA (2012-2017)
Figure Novartis Gastrointestinal Therapeutics Revenue Market Share in EMEA (2012-2017)
Table Pfizer Gastrointestinal Therapeutics Basic Information List
Table Pfizer Gastrointestinal Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer Gastrointestinal Therapeutics Sales (K Pcs) and Growth Rate (2012-2017)
Figure Pfizer Gastrointestinal Therapeutics Sales Market Share in EMEA (2012-2017)
Figure Pfizer Gastrointestinal Therapeutics Revenue Market Share in EMEA (2012-2017)
Table GlaxoSmithKline Gastrointestinal Therapeutics Basic Information List
Table GlaxoSmithKline Gastrointestinal Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Gastrointestinal Therapeutics Sales (K Pcs) and Growth Rate (2012-2017)
Figure GlaxoSmithKline Gastrointestinal Therapeutics Sales Market Share in EMEA (2012-2017)
Figure GlaxoSmithKline Gastrointestinal Therapeutics Revenue Market Share in EMEA (2012-2017)
Table Merck Gastrointestinal Therapeutics Basic Information List
Table Merck Gastrointestinal Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Merck Gastrointestinal Therapeutics Sales (K Pcs) and Growth Rate (2012-2017)
Figure Merck Gastrointestinal Therapeutics Sales Market Share in EMEA (2012-2017)
Figure Merck Gastrointestinal Therapeutics Revenue Market Share in EMEA (2012-2017)
Table UCB (Belgium) Gastrointestinal Therapeutics Basic Information List
Table UCB (Belgium) Gastrointestinal Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure UCB (Belgium) Gastrointestinal Therapeutics Sales (K Pcs) and Growth Rate (2012-2017)
Figure UCB (Belgium) Gastrointestinal Therapeutics Sales Market Share in EMEA (2012-2017)
Figure UCB (Belgium) Gastrointestinal Therapeutics Revenue Market Share in EMEA (2012-2017)
Table F. Hoffmann-La Roche Gastrointestinal Therapeutics Basic Information List
Table F. Hoffmann-La Roche Gastrointestinal Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche Gastrointestinal Therapeutics Sales (K Pcs) and Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche Gastrointestinal Therapeutics Sales Market Share in EMEA (2012-2017)
Figure F. Hoffmann-La Roche Gastrointestinal Therapeutics Revenue Market Share in EMEA (2012-2017)
Table Eli Lilly Gastrointestinal Therapeutics Basic Information List
Table AstraZeneca Gastrointestinal Therapeutics Basic Information List
Table Procter & Gamble Gastrointestinal Therapeutics Basic Information List
Table Eisai Gastrointestinal Therapeutics Basic Information List
Table Shire Pharmaceuticals Gastrointestinal Therapeutics Basic Information List
Table Ferring Pharmaceuticals Gastrointestinal Therapeutics Basic Information List
Table Kyowa Hakko Kirin Gastrointestinal Therapeutics Basic Information List
Table Salix Pharmaceuticals Gastrointestinal Therapeutics Basic Information List
Table Ono Pharmaceutical Gastrointestinal Therapeutics Basic Information List
Table TSD Japan Gastrointestinal Therapeutics Basic Information List
Table RedHill Biopharma Gastrointestinal Therapeutics Basic Information List
Table Kaken Pharmaceutical Gastrointestinal Therapeutics Basic Information List
Table Amgen Gastrointestinal Therapeutics Basic Information List
Table Synergy Pharmaceuticals Gastrointestinal Therapeutics Basic Information List
Table Ajinomoto Gastrointestinal Therapeutics Basic Information List
Table Kissei Pharmaceutical Gastrointestinal Therapeutics Basic Information List
Table Hutchison Medi Pharma Gastrointestinal Therapeutics Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Gastrointestinal Therapeutics
Figure Manufacturing Process Analysis of Gastrointestinal Therapeutics
Figure Gastrointestinal Therapeutics Industrial Chain Analysis
Table Raw Materials Sources of Gastrointestinal Therapeutics Major Manufacturers in 2016
Table Major Buyers of Gastrointestinal Therapeutics
Table Distributors/Traders List
Figure EMEA Gastrointestinal Therapeutics Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure EMEA Gastrointestinal Therapeutics Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Gastrointestinal Therapeutics Price (USD/Pcs) and Trend Forecast (2017-2022)
Table EMEA Gastrointestinal Therapeutics Sales (K Pcs) Forecast by Region (2017-2022)
Figure EMEA Gastrointestinal Therapeutics Sales Market Share Forecast by Region (2017-2022)
Table EMEA Gastrointestinal Therapeutics Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Gastrointestinal Therapeutics Revenue Market Share Forecast by Region (2017-2022)
Table Europe Gastrointestinal Therapeutics Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Europe Gastrointestinal Therapeutics Sales Market Share Forecast by Countries (2017-2022)
Table Europe Gastrointestinal Therapeutics Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Gastrointestinal Therapeutics Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Gastrointestinal Therapeutics Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Middle East Gastrointestinal Therapeutics Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Gastrointestinal Therapeutics Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Gastrointestinal Therapeutics Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Gastrointestinal Therapeutics Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Africa Gastrointestinal Therapeutics Sales Market Share Forecast by Countries (2017-2022)
Table Africa Gastrointestinal Therapeutics Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Gastrointestinal Therapeutics Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Gastrointestinal Therapeutics Sales (K Pcs) Forecast by Type (2017-2022)
Figure EMEA Gastrointestinal Therapeutics Sales Market Share Forecast by Type (2017-2022)
Table EMEA Gastrointestinal Therapeutics Sales (K Pcs) Forecast by Application (2017-2022)
Figure EMEA Gastrointestinal Therapeutics Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources